#AntibodyDrugConjugates
LightNews LightNews
4040rec.bsky.social
#GSK #EmmaWalmsley #LukeMiels #Blenrep #Arexvy #Shingrix #multiplemyeloma #PD1inhibitor #Jemperli #rectalcancer #antibodydrugconjugates #ADCs #HansohPharma #FDAapproval #longactingbiologic #depemokima #chronicrhinosinusitis #biologics #vaccines #shinglesvaccine #RSVvaccine
zurl.co/iumHW
Emma Walmsley upholds £40B sales target in her final GSK CEO report
Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. | Emma Walmsley and her ...
www.fiercepharma.com
November 3, 2025 at 4:00 PM
4040rec.bsky.social
#GSK #oncology #Blenrep #ADC #antibodydrugconjugates #prostatecancercandidate #Syndivia #advancedcastrationresistantprostatecancer #CRPC #mCRPC #multiplemyeloma #multiplemyelomaADC #prostatecancer #B7H3targetedADC #Hansoh #osteosarcoma #ESMO #GeminiMabconjugationtechnology
zurl.co/8KpGz
As Blenrep returns, GSK adds another ADC to cancer pipeline
GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.
zurl.co
November 3, 2025 at 2:44 PM
pharmaphorum.bsky.social
#GSK has boosted its pipeline of #antibodydrugconjugates for cancer, licensing a #prostatecancer candidate from #Syndivia in a deal that could be worth up to £268 million ($358 million).

pharmaphorum.com/news/blenrep...
As Blenrep returns, GSK adds another ADC to cancer pipeline
GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.
pharmaphorum.com
October 27, 2025 at 1:51 PM
obipharma.bsky.social
👏 Honored for OBI to take part in Biologics World Korea 2025
ADC Bioconjugate East Asia #ADCBio2025 (lnkd.in/e3cExQ-6)
#IMAPAC #BMK2025 #AntibodyDrugConjugates #PrecisionMedicine #LifeSciences

www.obipharma.com/news/biologi...
lnkd.in
September 26, 2025 at 7:50 AM
4040rec.bsky.social
#oncology #immunotherapy #AkariTherapeutics #novelPH1payload #targetedcancertherapy #PH1 #antibodydrugconjugates #ADCs #oncogenicmutations #DNAsplicing #neoantigens #missplicedproteins #effluxtransporters #oncogenicdrivers #PH1spliceosomemodulatorpayload
pharmatimes.com/news/akari-t...
Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy - PharmaTimes
Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used in its antibody drug conjugates
pharmatimes.com
August 11, 2025 at 9:09 AM
healthdivine.bsky.social
🧫🔗 Smart drugs, strong outcomes! ADCs are the future of precision oncology.
#AntibodyDrugConjugates #CancerTreatment #TargetedTherapy #Biopharma 🌍💉

www.marketresearchfuture.com/reports/anti...
Antibody Drug Conjugate Market Size, Trends Report 2035
Antibody Drug Conjugate Market Industry is expected to grow from 9.17(USD Billion) in 2024 to 22.5(USD Billion) by 2035. The Antibody Drug Conjugate Market CAGR (growth rate) is expected to be around ...
www.marketresearchfuture.com
July 11, 2025 at 12:52 PM
dfcibreastonc.bsky.social
Don't miss this recent Current Oncology Reports review on #AntibodyDrugConjugates in #BreastCancer: The Road Towards Biologically-Informed Selection and Sequencing pubmed.ncbi.nlm.nih.gov/39786525/
@ptarantinomd.bsky.social @ilanaschlam.bsky.social @stolaney1.bsky.social #AnaGarridoCastro
February 13, 2025 at 9:34 PM
tonnyjohnson.bsky.social
Degrader-Antibody Conjugates (DACs) – Transforming Immunotherapy
www.marinbio.com/degrader-ant...
#AntibodyDrugConjugates #ADC #PROTAC #MolecularGlue #TargetedProteinDegraders #TPD #DegraderAntibodyConjugates #DACs
#immunotherapy #cancer
Target Specific Cell Based Assays for DACs
Explore groundbreaking DACs combining antibodies & PROTACs for precise protein degradation. Revolutionizing therapy for cancer & autoimmune diseases.
www.marinbio.com
February 9, 2025 at 9:32 AM
oncodaily.bsky.social
#BGICC2025 #BreastCancer #AntibodyDrugConjugates #HopeRugo #CancerTreatment #OncologyInnovation #Medicine #Health #Oncology #OncoDaily #Cancer #bcsm
January 12, 2025 at 10:07 AM
oncodaily.bsky.social
#BGICC2025 #BreastCancer #AntibodyDrugConjugates #HopeRugo #CancerTreatment #OncologyInnovation #Medicine #Health #Oncology #OncoDaily #Cancer #bcsm
January 12, 2025 at 9:57 AM
dfcibreastonc.bsky.social
Check out this new systematic review and meta-analysis discussing #AntibodyDrugConjugates in patients with advanced/metastatic HER2-low-expressing #BreastCancer.
🔓https://pubmed.ncbi.nlm.nih.gov/39574495/
@ptarantinomd.bsky.social
December 17, 2024 at 2:30 PM
dfcibreastonc.bsky.social
Check out this recent review on the role of #AntibodyDrugConjugates in the treatment of patients with #BreastCancerBrainMetastases.
pubmed.ncbi.nlm.nih.gov/39529890/
#StaceyPan @drsarahsammons.bsky.social @nlinmd.bsky.social @stolaney1.bsky.social @ilanaschlam.bsky.social @ptarantinomd.bsky.social
December 6, 2024 at 7:32 PM
🚀 Diving into the future of medicine with the booming #AntibodyDrugConjugates (ADC) Market! 💉💊 These innovative therapies are set to revolutionize cancer treatment. Stay ahead of the game! shorturl.at/Uj19d #FutureOfMedicine #HealthRevolution #DrugDevelopment #Oncology #CancerTreatment
June 26, 2024 at 12:00 PM